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Background
Response to selective serotonin reuptake inhibitors
(SSRIs) in major depressive disorder has been suggested
to be influenced by variations in the serotonin transporter
gene (such as 5-HTTLPR and STin2) [1-3]. In addition, the
presence of concomitant physical complaints, particularly
pain-related complaints, also increases the risk on SSRI
non-response [4]. Since the serotonin transporter is
thought to be involved in pain development, an observed
association between serotonin transporter genotype and
SSRI non-response could be partially due to mediation of
the risk of comorbidity in depression. This study evaluates
the association between the presence of comorbidity
(with or without pain) and serotonin transporter geno-
type in major depressive disorder.
Materials and methods
For this study, 164 patients meeting the DSM-IV criteria
for major depressive disorder were included in the analy-
ses. Blood samples or buccal swabs were taken from all
participants to determine the 5-HTTLPR an STin2 geno-
type. Additional information was gathered through inter-
views and general practitioners' files. Reported
comorbidity was categorised according to level of associ-
ated pain (no pain, moderate pain and strong pain).The
association between genotype and comorbidity was
assessed using logistic regression.
Results
More comorbidity was reported by patients with the 5-
HTTLPR s/s genotype compared to patients with the s/l
and l/l genotype (65% versus 44.4 and 48.3%). These
patients also reported more comorbidity associated with
strong pain (52.5% versus 38.1 and 36.2%). For STin2,
patients with the 10/10 genotype only reported more
comorbidity not associated with pain compared to the 10/
12 and 12/12 genotype (8.0% versus 3.0 and 2.9%).
Patients with the 5-HTTLPR s/s genotype appeared to have
an increased risk of developing physical complaints with
painful symptoms; Odds Ratio (OR) = 2.33 (95% CI 0.92-
5.89). For STin2, patients with the 10/10 genotype
seemed to have an non-significant increased risk of devel-
oping comorbidity without painful symptoms; OR = 2.27
(95% CI 0.27-19.32). No elevated risks were found in
patients heterozygote for 5-HTTLPR or STin2.
Discussion
Our findings point to a slightly increased risk of develop-
ing comorbidity (with or without painful symptoms) with
the 5-HTTLPR s/s and the STin2 10/10 genotype, these
finding are not sufficient to exclude serotonin transporter
genotype as a possible risk factor for SSRI non-response.
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